证券记录 · 已归档季度
AHCO
AdaptHealth Corp. · Healthcare · Medical - Devices
16被追踪持有人
+1Δ持有人
45.46M持有股份
$406.86M报告持仓市值
+2新建仓位
−1清仓
动量输入(同类管理人):
持有人广度 +6.7% ·
股份流向 -0.5% ·
净新建仓位 +6.2%
· 公式
持有人分散化:持有人数增多,合计持仓比例缩小。
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 109.95K | $661,406 | n/a | n/a |
| Q2 2026 | 90 | -1 | 72.87M | $759.46M | +5 | −6 |
| Q1 2026 | 94 | +1 | 70.41M | $837.57M | +8 | −7 |
| Q4 2025 | 93 | +1 | 73.49M | $731.97M | +1 | n/a |
| Q3 2025 | 16 | +1 | 45.46M | $406.86M | +2 | −1 |
| Q2 2025 | 12 | -1 | 44.17M | $416.50M | +2 | −3 |
| Q1 2025 | 10 | +2 | 8.72M | $94.54M | +3 | −1 |
| Q4 2024 | 8 | -2 | 7.78M | $74.03M | n/a | −2 |
| Q3 2024 | 9 | +1 | 7.21M | $80.97M | +1 | n/a |
| Q2 2024 | 8 | n/a | 4.34M | $43.45M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 15.25M | +0.9% | $136.50M | 0.0% | ▲ Add | 2 | SEC ↗ ×14 |
| 2 | The Vanguard Group ✦ (被动) | 11.28M | -4.9% | $100.93M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | Fidelity (FMR) ✦ | 8.99M | +0.1% | $80.49M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 4 | State Street Global Advisors ✦ (被动) | 4.36M | 0.0% | $39.03M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 2.61M | +5.9% | $23.34M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Morgan Stanley ✦ | 809.20K | n/a | $7.24M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 7 | AQR Capital Management ✦ | 498.65K | +17.7% | $4.46M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 8 | JPMorgan Chase ✦ | 400.28K | n/a | $3.58M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 9 | Goldman Sachs Group ✦ | 293.79K | n/a | $2.63M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 10 | D. E. Shaw & Co. ✦ | 266.50K | +11.7% | $2.39M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | Renaissance Technologies ✦ | 222.87K | -1.5% | $1.99M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Millennium Management ✦ | 186.11K | +1168.5% | $1.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 108.26K | -72.0% | $968,945 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 87.92K | +7.8% | $787,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Marshall Wace ✦ | 56.70K | 新增 | $507,438 | 0.0% | New | 1 | SEC ↗ ×2 |
| 16 | Gotham Asset Management ✦ | 38.74K | 新增 | $346,714 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $507,438 | 0.0% |
| Gotham Asset Management | $346,714 | 0.0% |
已清仓
| Adage Capital Partners | $188,600 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 239 持有人, 141.33M 股份, $1.65B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
Aug 07
WOLF DALE B
Director · 20.00K 股 @ 5.86 · $117,200
Aug 06
WOLF DALE B
Director · 20.00K 股 @ 6.37 · $127,400
Aug 06
SAMET KENNETH A
Director · 23.50K 股 @ 6.38 · $149,930
公开市场卖出 (S)
在我们的覆盖窗口内无内部人士公开市场卖出记录。
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Oct 13
SC 13G/A: REINHART PARTNERS, LLC.
Oct 08
SC 13G/A: DIMENSIONAL FUND ADVISORS LP
数据来源: 持股数据来源于已解析的13F普通股持仓(被追踪范围,变动对比集);内部人行为来自Form 3/4/5;重大持股来自Schedule 13D/13G;所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据